1. Home
  2. CELU vs AWRE Comparison

CELU vs AWRE Comparison

Compare CELU & AWRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CELU
  • AWRE
  • Stock Information
  • Founded
  • CELU 2016
  • AWRE 1986
  • Country
  • CELU United States
  • AWRE United States
  • Employees
  • CELU N/A
  • AWRE N/A
  • Industry
  • CELU Biotechnology: Pharmaceutical Preparations
  • AWRE Computer Software: Prepackaged Software
  • Sector
  • CELU Health Care
  • AWRE Technology
  • Exchange
  • CELU Nasdaq
  • AWRE Nasdaq
  • Market Cap
  • CELU 42.2M
  • AWRE 34.8M
  • IPO Year
  • CELU N/A
  • AWRE 1996
  • Fundamental
  • Price
  • CELU $1.63
  • AWRE $1.58
  • Analyst Decision
  • CELU
  • AWRE
  • Analyst Count
  • CELU 0
  • AWRE 0
  • Target Price
  • CELU N/A
  • AWRE N/A
  • AVG Volume (30 Days)
  • CELU 102.4K
  • AWRE 34.8K
  • Earning Date
  • CELU 12-06-2024
  • AWRE 03-05-2025
  • Dividend Yield
  • CELU N/A
  • AWRE N/A
  • EPS Growth
  • CELU N/A
  • AWRE N/A
  • EPS
  • CELU N/A
  • AWRE N/A
  • Revenue
  • CELU $48,200,000.00
  • AWRE $17,389,000.00
  • Revenue This Year
  • CELU N/A
  • AWRE N/A
  • Revenue Next Year
  • CELU $233.89
  • AWRE N/A
  • P/E Ratio
  • CELU N/A
  • AWRE N/A
  • Revenue Growth
  • CELU 225.94
  • AWRE N/A
  • 52 Week Low
  • CELU $1.00
  • AWRE $1.35
  • 52 Week High
  • CELU $5.69
  • AWRE $2.97
  • Technical
  • Relative Strength Index (RSI)
  • CELU 46.69
  • AWRE 46.94
  • Support Level
  • CELU $1.64
  • AWRE $1.52
  • Resistance Level
  • CELU $2.40
  • AWRE $1.74
  • Average True Range (ATR)
  • CELU 0.20
  • AWRE 0.08
  • MACD
  • CELU 0.01
  • AWRE -0.01
  • Stochastic Oscillator
  • CELU 17.20
  • AWRE 27.27

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from bio-banking segment.

About AWRE Aware Inc.

Aware Inc is a provider of software and services to the biometrics industry. The company's software products are used in government and commercial biometrics systems to identify or authenticate people. The government applications of biometrics systems include border control, visa applicant screening, law enforcement, national defense, intelligence, secure credentialing, access control, and background checks. Its commercial applications include user authentication for login to mobile devices, computers, networks, and software programs, user authentication for financial transactions and purchases. Its geographical segments include the United States, the United Kingdom, and the Rest of the world, out of which it derives maximum revenue from United States.

Share on Social Networks: